New Delhi, July 27:
Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Secretary of Department of Biotechnology (DBT) Renu Swarup said on Monday.
This is an essential step because it is necessary to have data within the country before the vaccine is administered to Indians, Ms Swarup told PTI.
The Serum Institute of India, the largest vaccine maker in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it is ready. Trials results for the first two phases were published earlier this month.